Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
As one of the most common microvascular complications of diabetes mellitus, diabetic nephropathy（DN）is a common cause of end-stage renal disease（ESRD）.Sodium-glucose cotransporter 2（SGLT-2）inhibitor, a new type of hypoglycemic agent, may effectively lower blood glucose, improve renal hyperfiltration...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Chinês |
| Argitaratua: |
Editorial Department of Journal of Clinical Nephrology
2021-01-01
|
| Saila: | Linchuang shenzangbing zazhi |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.lcszb.com/thesisDetails?columnId=57905330&Fpath=home&index=0 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|